10x Genomics (TXG) Stock Highlights

14.04 | +3.16%

2024-12-21 03:38:23

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Statistics

Range Today

13.41 14.44

Volume Today 2.02M

Range 1 Year

12.95 57.9

Volume 1 Year 433.11M

Range 3 Year

12.95 154.1

Volume 3 Year 1.02B

Range 10 Year

12.95 208.99

Volume 10 Year 1.41B

Highlights

Market Capitalization 1.89B (small)

Floating Shares 104.96M

Current Price 14.04

Price To Earnings -10.92

Price To Revenue 2.51

Price To Book 2.62

Earnings Per Share -1.47

Payout Ratio 0%

Performance

Latest +3.16%

1 Month +3.16%

3 Months -40.2%

6 Months -28.66%

1 Year -75.4%

3 Years -90.15%

5 Years -78.27%

10 Years -74%

Benchmarks

Market Capitalization

5 / 35

Gross Profits

11 / 31

Total Revenue

18 / 33

Total Rank

29 / 35

Free Cashflow

31 / 34

Performance 5 years

24 / 35

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.